Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
The graph clearly shows at 31 weeks a positive divergence from combo therapy. In fact even better than in earlier weeks. If this trend continues, mono therapy will be used in phase 3. It is my opinion that the SOC combo kept overall results down and led to the stabilization comments. But mono therapy could get exciting.
Can you imagine in the next poster presentation graph if we saw the mono therapy patients continue to see improvement over Combo drug and of course SOC ?
Micro Floats DRYS and TOPS (400k and 600K)
TOPS hasn't started yet.
TOPS 600k micro float !!
SHIP only has 600k in float !
View Poster
You are coorect. On the poster slide there does show better MMSE scores with Anavex 2-73 alone vs combo with Donepezil
“Safety and Efficacy 31 Week Data of Anavex 2-73 in a Phase 2a Study in Mild-to-Moderate Alzheimer’s Disease Patients” AAIC Canada 2016
It starts at 6:55-7:00 on the interview.
How do u interpret this, I thought Mono therapy was showing better results than combo.
XENA, In regards to #8, I thought on the last update we received that mono therapy was showing better results than combo drug. It was the results of both studies that showed stabilization of disease but if you removed combo data, mono therapy looked much better. Can you clarify Misslings statement?
Where are the Aussie updates ? Did AVXL quiet the news stories there?
Contracted backlog of $67.5 million through 2017 and $502.7 million of
bids outstanding.
BUYING
You're Welcome. My next pick is AVXL
Micro float to $10+ possible
Oppenheimer initiates with a $50 PT
Prob All cash deal !
Conference Call next week. Could explode higher !
Earnings early November..Could explode !
Does this highlighted area suggest that treated patients will be there to answer questions? If that is the case, that is huge and media will be all over that !
BTUUQ hasn't even got an EC formed yet and its up 65% today !!
When is 41 week data? Anyone know? And also BIIB should announce advancement of positive testing soon ! !
November 2nd Conference Call and Amgens accelerated investment means big things coming !! $12+ imo.
Looks like BBEPQ is next with the judge ruling for an EC ! !
BTUUQ went from $1 to $11 in a few days, Buying more BBEPQ Monday.
More Cash than stock gets this deal done fast !!
ALIBABA FACTS : Users 434 million people, Monthly active users 427 million, # of annual orders: 12.7 BILIION ! ! PYPL will double imo.
BTUUQ from $1 to $11 in one week..go BBEPQ !
200 million in revenues coming "Our current annual revenue run rate of over $100 million combined with the $100 million of annual revenue we expect from this partnership starting in 2017, should help us deliver stronger than expected growth in 2017 and beyond," said John Melo"
Amazing news conference $10+ imo
AVXL has a better depression drug and working both BIIB and Michael J Fox Foundation.
Another UPLMQ !
BBPPQ will trade like GST.A
BBEPQ is like GST or UPLMQ. BBPPQ is like GST.A
GST.A chart will equal BBPPQ chart imo.
Wow. UPLMQ now over $6 up from .16c. BBEPQ looks to go much higher.
UPLMQ now over $6 up from .16c. BBEPQ may go higher.
Post 2517 a must read !
Higher oil again !!
Both should go higher as oil continues its rise today.
News : HPQ will sell Go Pro Style cameras made by LCLP. Although I hear LCLP's cameras are superior. Dash cams and cloud platform too ! LCLP along with Mobeego battery. loved by pokemon players will explode higher.
HPQ will sell Go Pro Style cameras made by LCLP. Although I hear LCLP's cameras are superior. Dash cams and cloud platform too ! LCLP along with Mobeego battery. loved by pokemon players will explode higher.
A Biogen possibility : BIIB could have suggested the data collection firm to verify these amazing results in Alzheimers so they can make a substantial offer and verify the cost to shareholders and reinstate a leadership role in ALZ treatment. Bonus would also be to acquire this safe medicine that crosses the brain barrier and seems to work in many CNS diseases better than current treatments.